Mark Robert Gillrie
Impact in
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Complement system in diseases
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
- Immune cells in cancer 3
- Complement system in diseases 3
-
- Malaria Research and Control 8
- Mosquito-borne diseases and control 3
- Co-authors
- Roger Dale Kamm (8 shared papers)May Ho (12 shared papers)Kristina Haase (4 shared papers)Giovanni S. Offeddu (5 shared papers)Shevaun P. Davis (7 shared papers)Kristine Lee (5 shared papers)Cynthia Hajal (2 shared papers)D. Channe Gowda (2 shared papers)
- Journals
- Advanced Science (3 papers)Biomaterials (3 papers)Nature Medicine (2 papers)The FASEB Journal (2 papers)American Journal Of Pathology (2 papers)
- Partner nations
- CanadaUnited StatesSingapore
In The Last Decade
Mark Robert Gillrie
27 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Immunology 344
- Infectious Diseases 291
- Public Health, Environmental and Occupational Health 353
- Genetics 100
- Oncology 204
Countries citing papers authored by Mark Robert Gillrie
This map shows the geographic impact of Mark Robert Gillrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Robert Gillrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Robert Gillrie more than expected).
Fields of papers citing papers by Mark Robert Gillrie
This network shows the impact of papers produced by Mark Robert Gillrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Robert Gillrie. The network helps show where Mark Robert Gillrie may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Robert Gillrie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 197 | |
| 2 | 2008 | 194 | |
| 3 | 2021 | 173 | |
| 4 | 2020 | 111 | |
| 5 | 2012 | 101 | |
| 6 | 2019 | 90 | |
| 7 | 2019 | 77 | |
| 8 | 2017 | 69 | |
| 9 | 2007 | 65 | |
| 10 | 2011 | 54 | |
| 11 | 2015 | 49 | |
| 12 | 2022 | 43 | |
| 13 | 2018 | 42 | |
| 14 | 2022 | 33 | |
| 15 | 2011 | 29 | |
| 16 | 2010 | 29 | |
| 17 | 2024 | 26 | |
| 18 | 2024 | 21 | |
| 19 | 2013 | 21 | |
| 20 | 2023 | 18 |
About Mark Robert Gillrie
Mark Robert Gillrie is a scholar working on Immunology, Public Health, Environmental and Occupational Health, Infectious Diseases, Oncology and Modeling and Simulation, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Malaria Research and Control (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), COVID-19 Clinical Research Studies (3 papers), Mosquito-borne diseases and control (3 papers), Immune cells in cancer (3 papers), Complement system in diseases (3 papers), Cancer Cells and Metastasis (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Immunology (344 citations), Infectious Diseases (291 citations), Public Health, Environmental and Occupational Health (353 citations), Genetics (100 citations) and Oncology (204 citations). Mark Robert Gillrie has collaborated with scholars based in Canada, United States and Singapore. Frequent co-authors include Roger Dale Kamm, May Ho, Kristina Haase, Giovanni S. Offeddu, Shevaun P. Davis, Kristine Lee, Cynthia Hajal, D. Channe Gowda, Bryan G. Yipp and Nathaniel J. Brittain. Their work appears in journals such as Advanced Science, Biomaterials, Nature Medicine, The FASEB Journal and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.